About

Jeff Sharman, M.D., is a hematologist-oncologist in Eugene, Oregon, and one of the world's leading experts in chronic lymphocytic leukemia (CLL). For more than two decades, he has helped shape the evolution of CLL treatment, contributing to the development and study of therapies that transformed the disease from one treated primarily with chemotherapy into one managed with highly effective targeted medicines.

Dr. Sharman serves as Medical Director of Hematology Research for the US Oncology Research Network, one of the largest community-based cancer research organizations in the world. Throughout his career, he has led clinical trials that have advanced the care of patients with leukemia and lymphoma and has authored approximately 100 scientific publications, including articles in The New England Journal of Medicine and The Lancet.

A graduate of the University of California, San Diego, Dr. Sharman earned his medical degree from the University of California, Davis, completed his residency training at Massachusetts General Hospital and Harvard Medical School, and pursued fellowship training in hematology and oncology at Stanford University.

He has lectured throughout North America, Europe, Asia, South America, and Africa and remains deeply committed to physician education and patient advocacy.

Dr. Sharman lives in Oregon with his wife, Anne, their three children, and their dog, Newton. He enjoys long walks, family adventures, and the outdoors. Ghosts in the Blood: The Extraordinary History of Chronic Lymphocytic Leukemia is his first book.